Use of a polymerase chain reaction assay to study response to oxytetracycline treatment in experimental Candidatus Mycoplasma haemolamae infection in alpacas.

Department of Biomedical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, OR 97331, USA.
American Journal of Veterinary Research (Impact Factor: 1.21). 10/2009; 70(9):1102-7. DOI: 10.2460/ajvr.70.9.1102
Source: PubMed

ABSTRACT To develop a PCR assay for Candidatus Mycoplasma haemolamae (CMhl) infection in alpacas and use it to study the efficacy of oxytetracycline treatment and development of a subclinical carrier state.
8 healthy adult alpacas.
Alpacas initially had negative results for CMhl in blood samples via PCR assay and were experimentally infected with CMhl; 4 were treated with oxytetracycline, and 4 were not treated. All were monitored regularly via PCR assay, blood smear examination, PCV, rectal temperature, and physical examination. At 6 months after treatment, all alpacas were immunosuppressed by administration of dexamethasone and tested for CMhl.
7 of 8 alpacas had positive PCR assay results 4 to 6 days after experimental infection. When organisms were detectable on a blood smear, they were seen 2 to 6 days after positive results of PCR assay. Infection was often associated with mild anemia that was usually transient. No alpacas became hypoglycemic. Oxytetracycline treatment was not associated with faster clearance of organisms or resolution of anemia, and 4 of 4 treated alpacas still had positive results of PCR assay when immunosuppressed 6 months later; 0 of 3 nontreated alpacas had positive results of PCR assay following immunosuppression. Transient fever was detected in 3 alpacas during immunosuppression.
The PCR assay was more sensitive than blood smear examination for detection of infection. Clinical signs, anemia, and fever were not necessarily associated with infection. Oxytetracyline administration did not consistently clear CMhl infection. Although treated with oxytetracycline, infected alpacas remained chronic carriers.

1 Bookmark
  • [Show abstract] [Hide abstract]
    ABSTRACT: This is the first report of detection of Candidatus Mycoplasma haemolamae in alpacas in England. The primary case occurred in a three year-old male alpaca in the south-east of England which presented with a history of progressive weight loss, lethargy, swelling of the scrotum and pale mucous membranes. Blood smear examination revealed a moderate, regenerative anaemia, with numerous small basophilic coccoid structures consistent with Candidatus M haemolamae. To confirm the presence of Candidatus M haemolamae, a portion of the 16S rDNA gene was amplified and analysed by denaturing gradient gel electrophoresis (DGGE). 16S rDNA gene sequencing showed a 99.8 per cent homology with Candidatus M haemolamae sequences deposited in GenBank. Subsequently, a cross-sectional study was carried out to investigate the presence of Candidatus M haemolamae infection in the alpaca herd from which the primary case was detected (n=131). Blood smear examinations and PCR with DGGE were used and compared with a species-specific PCR. The prevalence of infection when PCR positive results were combined was 29 per cent. A substantial agreement between the PCR/DGGE and the species-specific PCR was found (κ=0.86). A significant association was also found between age and infection (P=0.04) while no significant association was found with sex or origin.
    The Veterinary record. 07/2012; 171(3):71.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We report the complete genome sequence of "Candidatus Mycoplasma haemolamae," an endemic red-cell pathogen of camelids. The single, circular chromosome has 756,845 bp, a 39.3% G+C content, and 925 coding sequences (CDSs). A great proportion (49.1%) of these CDSs are organized into paralogous gene families, which can now be further explored with regard to antigenic variation.
    Journal of bacteriology 11/2012; 194(22):6312-3. · 2.69 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Mycoplasma haemolamae from dam to cria, whether colostral transmission of M. haemolamae occurs and provide preliminary data on colostral M. haemolamae specific antibody from pregnant alpacas on a farm with known prevalence of infection. M. haemolamae specific PCR was performed on blood and colostrum from pregnant alpacas and their cria (n = 52 pairs). Indirect fluorescent antibody testing was performed on a subset (n = 43) of the colostrum samples. Total immunoglobulin concentrations of colostrum and cria sera and M. haemolamae specific IgG (prior to and after ingesting colostrum) were determined by turbidometric immunoassay and indirect fluorescence antibody testing respectively. Sixteen of 52 dams (30.7%) pre-partum and one of 52 cria post-partum (1.9%; prior to ingesting colostrum) were PCR positive for M. haemolamae, while 36/52 dams (69%) and 51/52 cria (98%) tested negative for M. haemolamae by PCR. All 43 colostrum samples and 52 of 52 post-colostrum cria blood samples (100%) were negative by PCR. The dam giving birth to the M. haemolamae PCR positive cria was PCR negative. Statistically, it was no more likely for a PCR positive dam to give birth to a M. haemolamae, PCR positive cria (prior to colostrum ingestion) than a PCR negative dam (p = 0.3077). M. haemolamae specific IgG was present in 22 of 43 (51%) of colostrum samples at a 1:10 dilution and 14 of 22 (64%) at a 1:100 dilution. There was no relationship between the PCR status of the dam and whether or not M. haemolamae specific antibodies were present in colostrum. Among the animals tested, in utero transmission of M. haemolamae was rare (1/52 pre-colostral alpaca cria), and all colostrum samples were negative for M. haemolamae by PCR. These data indicate that colostrum from positive dams is unlikely to harbor this parasite and therefore does not serve as a source of infection to newborn cria. Colostrum derived from both PCR positive and negative dams contained M. haemolamae specific antibodies. Our findings suggest that M. haemolamae specific antibodies may play a role in immunity to this hemoparasite; however, challenge studies are necessary to fully evaluate the role of M. haemolamae specific antibodies. Furthermore, antibody prevalence and detectable titers may provide different estimates than those available from current PCR based prevalence studies. Our findings also suggest that M. haemolamae isolates from geographically distinct regions do not differ significantly from each other.
    Small Ruminant Research 01/2012; 106:181-188. · 1.10 Impact Factor